SPILF update on bacterial arthritis in adults and children

J P Stahl1, E Canouï2, P Pavese3

  • 1Université Grenoble Alpes, Maladies Infectieuses, 38700, France.

Insights

This update provides guidance on antibiotic management for bacterial arthritis, emphasizing optimized dosing and administration for bone and joint infections. Recommendations cover dosage adjustments for specific conditions and treatment durations for various bacterial pathogens.

Area of Science:

  • Infectious Diseases
  • Rheumatology
  • Pharmacology

Background:

  • The French Society of Rhumatology (SFR) released updated guidelines for bacterial arthritis in 2020.
  • This document supplements the SFR update, focusing on specific antibiotic strategies for bone and joint infections.

Framework:

  • Recommendations emphasize antibiotics with optimal bone and joint penetration.
  • Dosage optimization based on pharmacokinetic/pharmacodynamic (PK/PD) parameters is crucial.

Implementation:

  • High-dose intravenous betalactams are recommended, utilizing continuous or intermittent infusion.
  • Dosage adjustments for obesity and renal insufficiency are provided.
  • Transition to oral antibiotics is advised once blood cultures are negative and clinical symptoms improve.

Implications:

  • Specific treatment durations are outlined: 6 weeks for Staphylococcus aureus, 4 weeks for other bacteria, and 7 days for Neisseria.
  • Consultation with an infectious disease (ID) physician is recommended for Enterobacter infections with high-dose susceptibility.
  • Optimized antibiotic therapy can improve outcomes for bacterial arthritis.

Related Concept Videos

Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
50
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
151
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
23
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
406
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
1.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.7K